Pharmaceuticals & Biotechnology

Amphastar Pharmaceuticals, Inc. CEO pay

Jacob Liawatidewi, of Production and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd. Fiscal year 2025, as reported to the SEC.

Total compensation

$2M

$2,037,856 for fiscal 2025: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2026-04-13SEC accession number 0001297184-26-000023

In context

The median chief executive among 21 Pharmaceuticals & Biotechnology companies with $500M – $1B in revenue was paid $7.1M. The middle half ranged from $3.5M to $14.5M.

Jacob Liawatidewi's total is below that median.

See how your pay compares to Amphastar Pharmaceuticals, Inc.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: Amphastar Pharmaceuticals, Inc.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2025. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-10-28. Not financial, legal or compensation-consulting advice.